eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | multiple endocrine neoplasia type 1 |
| Comorbidity | C0020502|hyperparathyroidism |
| Sentences | 21 |
| PubMedID- 22584724 | Additionally, short-term and medium-term calcium and parathyroid hormone values after parathyroidectomy in patients with primary hyperparathyroidism associated with multiple endocrine neoplasia type 1 are discussed. |
| PubMedID- 22584713 | Primary hyperparathyroidism associated with multiple endocrine neoplasia type i (hyperparathyroidism/multiple endocrine neoplasia type 1) differs in many aspects from sporadic hyperparathyroidism, which is the most frequently occurring form of hyperparathyroidism. |
| PubMedID- 23363383 | Also covered is the role of pharmacotherapy in controlling acid hypersecretion and other hormonal hypersecretory states these patients may develop, including hyperparathyroidism in patients with multiple endocrine neoplasia type 1 and zes; tumor localization; and the treatment of advanced metastatic disease. |
| PubMedID- 19650788 | Bone mineral density analysis in patients with primary hyperparathyroidism associated with multiple endocrine neoplasia type 1 after total parathyroidectomy. |
| PubMedID- 21776381 | Known risk factors for primary hyperparathyroidism include abnormalities of the prad1, men1, and hrpt2 genes that encode for cyclin d1, menin, and parafibromin, respectively. |
| PubMedID- 20972944 | Somatostatin analogues do not affect calcium metabolism in patients with acromegaly and primary hyperparathyroidism [corrected] due to men 1-like syndrome. |
| PubMedID- 26031271 | Primary hyperparathyroidism in multiple endocrine neoplasia type i usually affects all parathyroid glands, making focused parathyroidectomy (fp) inappropriate. |
| PubMedID- 22584718 | Conversely, hyperparathyroidism associated with multiple endocrine neoplasia type 1 (hyperparathyroidism/multiple endocrine neoplasia type 1) is an asynchronic, asymmetrical multiglandular disease and it is surgically approached by either subtotal parathyroidectomy or total parathyroidectomy followed by parathyroid auto-implant to the forearm. |
| PubMedID- 26191410 | In conclusion, we identified a novel pathogenic 14 bp deletion men1 mutation in a patient with hyperparathyroidism and gastrinoma. |
| PubMedID- 21747852 | Familial hyperparathyroidism associated with men1 and men2a and familial isolated hyperparathyroidism are also managed surgically [62–64]. |
| PubMedID- 20585352 | [10] recently demonstrated the effectiveness of long acting octreotide in the management of men1 patients with primary hyperparathyroidism and duodeno-pancreatic neuroendocrine tumour. |
| PubMedID- 24037737 | A 59-year-old woman with classic manifestations of hyperparathyroidism associated with multiple endocrine neoplasia type 1 presented with a right adrenal mass and two pituitary microadenomas on imaging studies. |
| PubMedID- 25262224 | A randomized, prospective trial of operative treatments for hyperparathyroidism in patients with multiple endocrine neoplasia type 1. |
| PubMedID- 21713580 | The optimal surgical treatment for primary hyperparathyroidism in men1 patients: a systematic review. |
| PubMedID- 22584719 | Primary hyperparathyroidism in multiple endocrine neoplasia type 1: when to perform surgery. |
| PubMedID- 20962866 | Parathyroid gland: hyperparathyroidism in men1 syndrome: time to operate. |
| PubMedID- 22735224 | Methods: forty-one patients with hyperparathyroidism associated with men1 who underwent parathyroidectomy between 1997 and 2007 were retrospectively studied. |
| PubMedID- 21318141 | Primary hyperparathyroidism in patients with multiple endocrine neoplasia type 1. |
| PubMedID- 22470073 | Primary hyperparathyroidism in men1 patients: a cohort study with longterm follow-up on preferred surgical procedure and the relation with genotype. |
| PubMedID- 20431882 | Background: subtotal parathyroidectomy (sptx) is the treatment of choice for hyperparathyroidism in a patient with multiple endocrine neoplasia type 1 (hpt-men-1). |
| PubMedID- 22508712 | Results: we report two patients with primary hyperparathyroidism due to multiple endocrine neoplasia type 1 who had their first parathyroidectomy at the national institutes of health. |
Page: 1